Navigation Links
New research project aims to improve cancer therapies using type I interferons
Date:4/23/2013

The immune system plays a decisive role in the fight against tumor cells. However, when tumor cells themselves prevent activation of the immune system, the immune system fails to destroy cancer cells. The cancer drug interferon-α could probably neutralize this blockade. This cytokine is being used successfully to treat various forms of cancer. However, some patients experience undesirable autoimmune reactions on administration of the drug. The German Cancer Aid (Deutsche Krebshilfe e.V.) is donating EUR 180,000 to fund a research project at the University Medical Center of Johannes Gutenberg University Mainz that is to identify mechanisms underlying the effects of the cancer drug interferon-α (IFN-α) when it comes to fighting cancer cells by means of the blockade of so-called immunological tolerance processes. In addition, the researchers want to discover novel approaches to increase the efficacy of type I interferons in the treatment of cancer.

Interferon-α can trigger autoimmune reactions in patients, i.e., pathological reactions of the immune system. Interferon-α has been seen to date as an active substance that boosts the immune system and fights tumor cells directly. It is used, for example, in the therapy of malignant melanomas, certain forms of leukemia and cutaneous T-cell lymphomas. "The immune system is usually able to effectively destroy cancer cells. At the same time, however, there are also so-called tumor-associated tolerance processes that protect the tumor cells from being destroyed by the immune system. Autoimmune reactions, which are known side effects of therapies with IFN-α, may indicate that this anti-tumor treatment blocks tolerance mechanisms and thus improves the immune system's natural ability for tumor rejection," explained Professor Dr. Kerstin Steinbrink, senior physician at the Department of Dermatology of the Mainz University Medical Center, which is supervising the research project "Analysis of the Effect of Type I Interferons on Immunological Tolerance Processes" funded by the German Cancer Aid. The purpose of this project is to analyze the effects of IFN-α and other type I interferons on various immune cells that exhibit tolerogenic potential in vitro and also in melanoma patients.

The knowledge gained through this project should contribute to the development of improved therapy strategies for overcoming tolerance mechanisms associated with tumors. An additional objective is to enhance the efficacy of therapy with type I interferons. Steinbrink's research team is looking to reduce potential side effects as much as possible.

"This research project is taking a patient-oriented approach. The research team led by Professor Dr. Kerstin Steinbrink will profit from its expertise in the area of immunological tolerance that it has gained over several years," said Professor Dr. Ulrich Frstermann, Chief Scientific Officer of the Mainz University Medical Center.


'/>"/>

Contact: Dr. Reneé Dillinger-Reiter
pr@unimedizin-mainz.de
49-613-117-7424
Johannes Gutenberg Universitaet Mainz
Source:Eurekalert

Related medicine news :

1. Should kids sit less or move more? CHEO Research answers
2. The Melanoma Research Alliance Foundation supports CNIO research
3. Deficiency in p53 anti-tumor protein delays DNA repair after radiation, Moffitt researchers say
4. Latest research shows 2 items are key to decrease symptoms and prolong survival for LMC patients
5. Wayne State researchers seek calcium channels to target cancer tumors
6. Medical Device Market: Peru & Philippines New Market Research Report Available At Researchmoz.us
7. Toothpaste and Toothbrush Manufacturing in China Industry Research Report – Now Available from IBISWorld
8. Medical Robotic Systems Market - New Market Research Report Published by Transparency Market Research
9. Sickle cell project named among Top 10 Clinical Research Achievements for 2012
10. Feinstein Institute Researcher provides insight into osteoarthritis
11. Cleveland Clinic Childrens Hospital research suggests transmission of respiratory viruses in utero
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... ... January 17, 2017 , ... The Sharie Withers ... has announced the latest beneficiary of their thriving community involvement program. The current ... to fulfilling the dreams of terminally ill patients. Donations to this worthy cause ...
(Date:1/17/2017)... , ... January 17, 2017 , ... Today, FloSports ... Wrestling announced a new agreement as part of a long-term extension of their ... and includes the airing of some of the sport’s premier events exclusively on FloWrestling.com ...
(Date:1/16/2017)... Battle Creek, MI (PRWEB) , ... January 17, 2017 , ... ... substance abuse located in Southwest Michigan, joined other volunteers and organizations in support of ... sees hundreds of children and families dressed up in colorful costumes of all designs ...
(Date:1/16/2017)... ... January 16, 2017 , ... ... demonstrate their groundbreaking GunSport•PRO® and EB15•LE® electronic earplugs at the NSSF SHOT Show ... Vegas, Booth #2809. The SHOT Show is the shooting, hunting and outdoor trade ...
(Date:1/16/2017)... ... 2017 , ... Houston dentist, Dr. Behzad Nazari, announces that ... and financing for orthodontics for a limited time. Complimentary for a limited time, ... orthodontic options. Walk-in, late-evening, Saturday, and same-day appointments are available. Antoine Dental also ...
Breaking Medicine News(10 mins):
(Date:1/16/2017)... 2017  An aneurysm develops due to the weakening of ... Aneurysms can occur in any artery, it happens most often ... blood to legs. Most aortic aneurysms occur in the section ... referred as abdominal aortic aneurysms, sometimes in the chest referred ... in the abdomen is about 2 cm but in the ...
(Date:1/16/2017)... 16, 2017  This report by Persistence Market ... market for the period 2016–2024. The primary objective ... information related to market opportunities in the global ... study demonstrates the various dynamics that are expected ... of the global peripherally inserted central catheters market ...
(Date:1/16/2017)... 2017 The global pacemaker market is expected ... a new report by Grand View Research, Inc. The ... of medical coverage is a key driving factor governing ... in these devices are supporting the expansion of this ... a high-impact growth rendering driver for this market. A ...
Breaking Medicine Technology: